Mereo BioPharma Group plc
NASDAQ:MREO · NASDAQ Global Market
+$0.03 today
Vol 2.58M · Avg 3.36M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-88.31%
Period High
$2.94
Period Low
$0.24
Latest
$0.32
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Capricor Therapeutics, Inc.
NASDAQ:CAPR
$1.28B
Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ:CTNM
$477.61M
Candel Therapeutics, Inc.
NASDAQ:CADL
$445.70M
Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO
$402.82M
Kyverna Therapeutics, Inc.
NASDAQ:KYTX
$364.78M
Silence Therapeutics plc
NASDAQ:SLN
$324.26M
AC Immune S.A.
NASDAQ:ACIU
$242.71M
ProQR Therapeutics N.V.
NASDAQ:PRQR
$174.37M
Aldeyra Therapeutics, Inc.
NASDAQ:ALDX
$114.91M
Immutep Limited
NASDAQ:IMMP
$55.57M
What is the latest MREO filing?
The latest filing shown is SC 13G/A dated May 15, 2026.
How many recent filings does MREO have?
Intrinsic Alpha currently shows 20 recent filings for MREO.
Explore More
Continue the stock analysis
Jump to another research area for this company.